In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...

The Chan Zuckerberg Initiative (CZI) reports its latest AI model aimed at helping researchers better understand how cells ...

The internationally renowned cancer centre is working on the project – billed as the UK's first large-scale, AI-powered radiology platform for cancer research – with digital transformation ...

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...

Agentic AI can help researchers shape hypotheses, work with complex data, and uncover insights, without needing a data ...

Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

Also this week, Pathos AI revealed that it has started patient dosing in a phase 1b/2a clinical trial of pocenbrodib, a CBP/p300 inhibitor that is the lead drug identified using its AI platform.

World-Leading Cancer Center, The Royal Marsden NHS Foundation Trust, Using AI to Push Boundaries of Cancer Research With NTT DATA and CARPL.ai Provided by Business Wire May 27, 2025, 8:00:00 AM ...

Ayub U, Ahmed Naqqvi SA, Jajja SA, et al. Automated risk stratification in localized prostate cancer using an AI-assisted framework. Presented at ASCO GU 2025, February 13-15, San Francisco ...

In 2020, AstraZeneca partnered with Qure.ai to leverage its technology for assessing chest X-rays and determining potential lung cancer risk. Ti Hwei How, AZ Vice President (International Oncology ...